Autres langues Alpine Immune Sciences, Inc.

Actions

ALPN

US02083G1004

Temps Différé Nasdaq Autres places de cotation 22:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
64,97 ^USD	+0,02 %		-.--%	+240,87 %

20/05	Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) a finalisé l'acquisition d'Alpine Immune Sciences, Inc. (NasdaqGM:ALPN) auprès d'un groupe d'actionnaires.	CI
10/05	L'accord entre Alpine Immune Sciences et Vertex Pharmaceuticals franchit une nouvelle étape	MT

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from NASDAQ Composite Index	20/05
Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders.	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from S&P TMI Index	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from S&P Biotechnology Select Industry Index	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from S&P Global BMI Index	20/05
Alpine Immune Sciences, Inc.(NasdaqGM:ALPN) dropped from NASDAQ Biotechnology Index	17/05
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	10/05
Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Alpine Immune Sciences Reports First Quarter 2024 Financial Results	09/05
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	09/05
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug	06/05
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN	26/04
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN	18/04
North American Morning Briefing : Stock Futures -2-	17/04
North American Morning Briefing : Stock Futures -2-	15/04
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN	12/04
North American Morning Briefing : Big Banks Kick -2-	12/04
Health Care Slips on Risk Bias -- Health Care Roundup	11/04
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024	11/04
MÄRKTE USA/Wall Street auf Erholungskurs - Nasdaq sehr fest	11/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Alpine Immune Sciences, Inc.

Actions

ALPN

US02083G1004

Autres langues

Filtres